ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC

FDA Drug Profile — D-33

ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including D-33. Available dosage form: solution.

Drug details

Generic Name
ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, and ZINC
Brand Names
D-33
Sponsor
DNA Labs, Inc.
NDC Codes
1
Dosage Forms
SOLUTION
Routes
SUBLINGUAL
Active Ingredients
ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, ZINC

Indications and Usage

INDICATIONS Epilepsy, irritations of the nerve.

Warnings

Warnings Use only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.